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Abstract
The Pandemic (H1N1) 2009 is spreading to numerous countries and causing many human deaths. Although the symptoms
in humans are mild at present, fears are that further mutations in the virus could lead to a potentially more dangerous
outbreak in subsequent months. As the primary immunity-eliciting antigen, hemagglutinin (HA) is the major agent for host-
driven antigenic drift in A(H3N2) virus. However, whether and how the evolution of HA is influenced by existing immunity is
poorly understood for A(H1N1). Here, by analyzing hundreds of A(H1N1) HA sequences since 1918, we show the first
evidence that host selections are indeed present in A(H1N1) HAs. Among a subgroup of human A(H1N1) HAs between
1918,2008, we found strong diversifying (positive) selection at HA1 156 and 190. We also analyzed the evolutionary trends
at HA1 190 and 225 that are critical determinants for receptor-binding specificity of A(H1N1) HA. Different A(H1N1) viruses
appeared to favor one of these two sites in host-driven antigenic drift: epidemic A(H1N1) HAs favor HA1 190 while the 1918
pandemic and swine HAs favor HA1 225. Thus, our results highlight the urgency to understand the interplay between
antigenic drift and receptor binding in HA evolution, and provide molecular signatures for monitoring future antigenically
drifted 2009 pandemic and seasonal A(H1N1) influenza viruses.
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Introduction
Since April 2009, a global outbreak caused by the swine-origin
2009 A(H1N1) influenza virus has spread to numerous countries
[1,2,3,4,5,6,7,8,9,10], which warranted the declaration of ‘‘Pan-
demic (H1N1) 2009’’ by the World Health Organization on June
11, 2009. As of September 6, there had been over 277,607 infected
individuals and at least 3,205 confirmed human deaths worldwide.
The Pandemic (H1N1) 2009 is not the first human pandemic
caused by A(H1N1) influenza virus. During 1918,1919, the
‘‘Spanish’’ A(H1N1) influenza virus swept across the globe,
infected ,25% of the entire population and claimed at least 50
million human lives worldwide [11]. In subsequent years,
A(H1N1) influenza virus continued to circulate among humans
and caused a number of severe outbreaks between 1920s and
1950s [12,13,14,15,16,17,18,19,20], in particular the A(H1N1)
epidemic in 1950,1951 with mortality exceeding those of the
1957 ‘‘Asian’’ and 1968 ‘‘Hong Kong’’ pandemics [18,19,20].
In 1957, A(H1N1) influenza virus disappeared, replaced by a
reassorted A(H2N2) influenza virus [21]. However, the
A(H1N1) influenza virus reappeared in 1977, with a close
genetic and antigenic similarity to those A(H1N1) viruses
isolated in 1950 [22,23,24], and has co-circulated with
A(H3N2) and type B influenza virus to cause seasonal human
epidemics ever since.
The same 1918 pandemic A(H1N1) influenza virus was also
spread to swine during 1918,1919, and became the so-called
‘‘classical’’ swine influenza [8,25,26,27], first isolated in North
American in 1930 [26] and in Europe in 1976 [28,29]. In 1979, a
novel lineage of avian-like A(H1N1) influenza virus, believed to
have derived from closely related Eurasia avian influenza viruses,
emerged in swine in Europe [30] and replaced the classical swine
A(H1N1) virus in this region [31,32,33]. These two classes of swine
A(H1N1) viruses displayed different evolutionary trajectories [34].
In1998, a new triple-reassortant A(H3N2) virus, derived from
North American avian, classical swine A(H1N1) and human
A(H3N2) viruses, caused outbreaks in North American swine
[35,36]. Mixing of the triple-reassortant H3N2 with established
swine lineages gave rise to H1N1 and H1N2 reassortant swine
viruses [37,38]. Since 2007, human infection caused by A(H1N1)
swine virus has become a health concern in the United States [7].
The 2009 A(H1N1) influenza virus has its origin as a reassortant
from a Eurasian avian-like swine A(H1N1) virus and a triple-
reassortant virus circulating in North American swine
[1,2,3,4,5,6,7,8]. As such, the 2009 A(H1N1) virus contains NA
and M from Eurasian avian-like swine A(H1N1) virus, and the
remaining genes from the triple-reassortant virus - PB2 and PA
(avian virus), PB1 (human A(H3N2)), and HA, NP and NS
(classical swine A(H1N1)) [1,2,3,4,5,6,7,8]. In a sense, we are
continuingly living in a pandemic that started in 1918 [27]. Thus,
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2009 pandemics. Notably, the second wave of the ‘‘Spanish’’
influenza in the fall of 1918 became much more lethal, peaked
within one month of the initial introductions in many communities
[11]. This makes influenza virologists and healthcare officials fear
that further mutations in the 2009 A(H1N1) virus could also lead
to a potentially more dangerous second wave in subsequent
months. Thus, in-depth studies on the 1918 pandemic strains as
well as their post-pandemic decedents should provide critical new
insights into the evolution of A(H1N1) in general, and the
pandemic potential of the 2009 A(H1N1) in particular.
HA is one of the two major glycoproteins on the surface of
influenza virus. It is the primary antigen that elicits host immune
response, and is also responsible for binding to sialic-acid receptors
and for mediating viral entry into host cells [39]. The hallmarks of
highly pathogenic influenza viruses among human population
include easy human-to-human transmission as a result of high
affinity of HA for human-like a(2,6) receptors, and significant
difference in sequence and antigenicity of HA with existing
seasonal and vaccine strains [1,2,39]. It has been demonstrated on
1918 A(H1N1) HA that HA1 D190 and D225 are key
determinants for effective binding to human-like a(2,6) receptors
and consequently high infectivity of the virus among human
population [11,40,41,42]. A single mutation D225G reduced the
binding affinity for a(2,6) receptors [41,42] and the infectivity of
the virus [40], while a double variant D190E/D225G rendered
the HA non-binding to a(2,6) receptors [41,42] and the virus non-
infectious [40].
In A(H3N2) virus, HA is the major agent for host-driven
antigenic drift [43,44]. However, it is unclear whether or not and,
if yes, how human immunity imposes selection on A(H1N1) HA.
In order to address this critical issue, we undertook a systematic
computational analysis of the evolution of H1 HA in the region of
HA1, which is the primary target for host immunity selection [43].
Recent years have witnessed an explosive expansion of available
computational methods for phylogenetic analysis of selective
pressure, including a variety of methods that look for different
types of positive selection such as diversifying selection, toggling
selection and directional selection [45,46,47,48,49,50,51,52,53,54]
implemented in software packages such as HyPhy [55], MrBayes
[56,57] and PAML [45]. Here we used PAML 4.0 [45] for
calculation of heterogeneous selection pressure at each codon and
HyPhy [55] for directional selection in 335 non-egg-adapted and
32 egg-adapted human A(H1N1) HA sequences. These sequences
were from A(H1N1) viruses isolated all around the globe between
1918,2009. In addition, we also analyzed 42 classical swine
A(H1N1) HA sequences for their close relationship to the 2009
A(H1N1) HA.
In PAML 4.0 [45], a number of models are available: the
branch models allow the v ratio to vary among branches in the
phylogenetic tree and can be used to detect positive selection on
particular branches [46,58]; the site models allow the v ratio to
vary among sites and can be used to detect positive selection at
particular sites [59,60]; the branch-site models allow the v ratio to
vary both among sites and among branches [61] and can be used
to detect positive selection that affects only a few sites in a few
branches.
In this analysis, a large dataset composed of over 300 sequences
was used to ensure sufficient representative sequences for the total
time span of 91 years, which made it impractical for the use of
branch-site models in our calculations. However, by separating the
sequences into distinct subgroups based on their phylogenetic
relationship and applying the site models in PAML 4.0 [45], we
successfully detected the branch and the specific sites therein that
were under host-driven positive selection. Our study revealed
differential evolutionary trends of A(H1N1) HA since 1918, which
provided molecular signatures for monitoring future antigenically
drifted 2009 pandemic and seasonal A(H1N1) influenza viruses.
Results and Discussion
Phylogenetic Analysis of Human A(H1N1) HA Sequences
Since 1918
It is known that egg-adapted influenza viruses tend to have non-
natural host-associated modifications at certain sites of HA
sequences [62,63,64]. To eliminate the effects of such modifica-
tions in our analysis, we selected only 333 HA sequences of
A(H1N1) viruses between 1918,2009 (as of July 10, 2009) with a
well-documented record that they had never been passaged in
chicken eggs at any stage. Furthermore, intragenic recombination
may give rise to false positives in subsequent detection of positively
selected codons [65], thus the Recombination Detection Program
(RDP3) [66] was used to make sure that all HA sequences used in
this study were free of recombination, agreeing with previous
observations that intragenic recombination is rare for HA [67].
The nucleotide sequences of 333 A(H1N1) HAs in the region of
HA1 including the signal peptide, were analyzed by the ClustalW
method [68]. The phylogeny tree suggested that these HA
sequences belong to two major groups: the majority of HA
sequences from 1918 to 2008 formed group I, and those of the
2009 A(H1N1) together with a strain isolated in 2007 formed
group II (Fig. S1). The separation of the 2009 A(H1N1) HAs from
HAs of established human A(H1N1) viruses between 1918,2008,
including the 1918 pandemic and the seasonal A(H1N1) viruses,
was consistent with the proposed swine origin of HAs in these
viruses [1,2,3,4,5,6,7,8]. The low sequence identity (,73%)
between the 2009 A(H1N1) HA with seasonal and vaccine
A(H1N1) HAs might explain why people were in general
immunologically naı ¨ve to the former [8,69]. In fact, there did
not exist cross-reactivity between the 2009 and seasonal A(H1N1)
viruses [8], nor did the vaccination with recent (2005,2009)
annual vaccines provide immune protection against the 2009
A(H1N1) virus [69].
Evidence for Host-Driven Antigenic Drift in Human
A(H1N1) HAs
In order to understand whether host-driven antigenic drift is
imposed on the evolution of HA1 of A(H1N1) virus, we used
likelihood ratio tests (LRT) in the software package PAML 4.0
[45] to identify the presence or absence of positive selection. In this
context, positive selection referred to a significant excess of amino-
acid altering (non-synonymous) substitutions over silent (synony-
mous) substitutions in nucleotide sequences. Large LRT values (or
small p-values) between alternative models and null models, such
as M2a vs. M1a, M8 vs. M7, or M8 vs. M8a, led to the rejection of
the null models.
Since HA sequences of group I was further divided into five
subgroups (Fig. S1), the PAML calculation was carried out on each
of these five subgroups and on group II (Table 1). For group I-i
that included three 1918 pandemic A(H1N1) HAs, in order to
increase the sample size, we also included two partial sequences,
A/London/1/1918 and A/London/1/1919 [11]. Except for the
subgroup I-v, all other subgroups of group I had very low LRT
values and large p-values (Table 1, 2), indicating predominantly
neutral or purifying selection. These results were consistent with
the overall low prevalence of A(H1N1) virus during the period of
1979,2006 [70], and agreed well with a previous study that
focused on 1995,2005 A(H1N1) isolates where no positive
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2006,2008 had v.10 and LRT.60, which provided strong
evidence for positive selection (Table 1, 2) and agreed with the
necessity to update the A(H1N1) vaccine strain using A/Brisbane/
59/07 for the 2008,2009 season. Group II including 73 HAs of
2009 A(H1N1) and one of 2007 A(H1N1) also had a very low
LRT rate ratio (Table 1, 2). Given the largely nonexistence of
human immunity against the 2009 A(H1N1), the lack of positive
selection among group II was expected. However, with more mild
infections rapidly propagating among human population in the
Table 1. The values of log-likelihood (l), dN/dS, and parameter estimates in CODEML analysis of human A(H1N1) Has.
Model l dN/dS Parameters estimates
I-i 1918,1919 (5 strains)
1
M0 (one-ratio) 2806.78 0.516 v=0.516
M1a (nearly neutral) 2805.91 0.323 p0=0.677 (p1=0.323), v0=0(v1=1)
M2a (positive selection) 2804.19 0.564 p0=0.963, p1=0(p2=0.037), v0=0(v1=1),v2=15.421
M7 (beta) 2805.92 0.300 p=0.005, q=0.012
M8a (beta&v=1) 2805.91 0.323 p0=0.846 (p1=0.154), p=0.005, q=0.020, vs=1
M8 (beta&v.1) 2804.19 0.561 p0=0.963 (p1=0.037), p=0.005, q=7.228, vs=15.242
I-ii 1979,2000 (45 strains)
2
M0 (one-ratio) 22489.23 0.223 v=0.223
M1a (nearly neutral) 22486.25 0.242 p0=0.855 (p1=0.145), v0=0.113 (v1=1)
M2a (positive selection) 22486.25 0.242 p0=0.855, p1=0.056 (p2=0.089), v0=0.113 (v1=1), v2=1
M7 (beta) 22485.63 0.232 p=0.327, q=1.074
M8a (beta&v=1) 22485.63 0.232 p0=1(p1=0),p=0.327, q=1.074, vs=1
M8 (beta&v.1) 22485.63 0.232 p0=1(p1=0),p=0.327, q=1.074, vs=1
I-iii 2000,2001 (22 strains)
2
M0 (one-ratio) 21686.21 0.279 v=0.279
M1a (nearly neutral) 21684.58 0.261 p0=0.793 (p1=0.207), v0=0.068 (v1=1)
M2a (positive selection) 21683.09 0.287 p0=0.994, p1=0(p2=0.006), v0=0.225 (v1=1),v2=10.636
M7 (beta) 21684.52 0.265 p=0.046, q=0.127
M8a (beta&v=1) 21684.58 0.261 p0=0.793 (p1=0.207), p=7.211, q=98.93, vs=1
M8 (beta&v.1) 21683.10 0.287 p0=0.994 (p1=0.006), p=28.774, q=99,vs=10.638
I-iv 2001,2007 (89 strains)
2
M0 (one-ratio) 22720.83 0.187 v=0.187
M1a (nearly neutral) 22709.20 0.181 p0=0.883 (p1=0.117), v0=0.072 (v1=1)
M2a (positive selection) 22708.27 0.187 p0=0.906, p1=0.076 (p2=0.018), v0=0.085 (v1=1), v2=1.915
M7 (beta) 22708.99 0.183 p=0.137, q=0.612
M8a (beta&v=1) 22709.40 0.180 p0=0.885 (p1=0.115), p=7.871, q=98.995, vs=1
M8 (beta&v.1) 22708.82 0.186 p0=0.973 (p1=0.027), p=0.375, q=2.298, vs=1.936
I-v 2006,2008 (100 strains)
2
M0 (one-ratio) 23871.33 0.303 v=0.303
M1a (nearly neutral) 23813.28 0.241 p0=0.828 (p1=0.172), v0=0.082 (v1=1)
M2a (positive selection) 23782.07 0.313 p0=0.807, p1=0.188 (p2=0.005), v0=0.083 (v1=1), v2=11.142
M7 (beta) 23814.21 0.246 p=0.139, q=0.427
M8a (beta&v=1) 23812.40 0.231 p0=0.862 (p1=0.138), p=0.497, q=3.969, vs=1
M8 (beta&v.1) 23781.55 0.305 p0=0.994 (p1=0.006), p=0.180, q=0.546, vs=10.554
II 2007,2009 (74 strains)
2
M0 (one-ratio) 22374.98 0.277 v=0.277
M1a (nearly neutral) 22373.20 0.282 p0=0.922 (p1=0.078), v0=0.222 (v1=1)
M2a (positive selection) 22372.81 0.282 p0=0.922, p1=0.035 (p2=0.042), v0=0.222 (v1=1), v2=1
M7 (beta) 22373.21 0.281 p=1.218, q=3.079
M8a (beta&v=1) 22374.03 0.282 p0=0.945 (p1=0.055), p=3.243, q=10.201, vs=1
M8 (beta&v.1) 22372.81 0.282 p0=0.946 (p1=0.054), p=3.158, q=9.900, vs=1
1Due to the inclusion of two partial sequences of A/London/1/1918 and A/London/1/1919 in this subgroup, the analysis was performed on a total of 187 amino-acid
residues that covered the antigenic and receptor-binding sites in the region of HA1 (51,237) [11].
2 The analysis was performed on the first 340 residues of HA1
including the signal peptide.
doi:10.1371/journal.pone.0007789.t001
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positive selection in future isolates of 2009 A(H1N1) strains.
Identification of Positively Selected Codons in Human
A(H1N1) HAs
In order to understand how H1 HA sequences were positively
selected by human existing immunity, the CODEML [72]
program in PAML 4.0 was used on subgroup I-v in which about
0.6% codons were found to be under positive selection (Table 1,
2). Both M2a and M8 models identified HA1 156 and 190 with
greater than 95% posterior probabilities to be under positive
selection (Table 3). In previous studies, the antigenic structure of
H1 HA (A/PuertoRico/8/1934) had been determined to include
five distinct antigenic sites on the globular domain: Sa, Sb, Ca1,
Ca2 and Cb [73,74] (Fig. 1a). Both of these positively selected
codons were located on the site Sb (Fig. 1b). The focus of positive
selection on the Sb antigenic site was consistent with a cross-
reactivity analysis of various epidemic H1N1 strains using
monoclonal antibodies that it was under much higher pressure
for mutations [74].
HA1 138, 186, 190, 194, 225, 226 and 228 had been previously
shown to affect receptor binding to H1 HA [75,76]. Among them,
two residues, HA1 190 and 225, play predominant roles in
determining the receptor-binding specificity of H1 HA: D190/
D225 for a(2,6) receptors in humans, D190/G225 for a(2,6) and
a(2,3) receptors in swine, and E190/G225 for a(2,3) receptors in
avian [11,39,40,41,42,76]. Although changes at these two sites had
been previously reported to cause antigenic drift in A(H1N1)
epidemic strains [77], it was a somewhat common belief that key
determinants of receptor-binding specificity are in general not
subject to selection. Thus, the strong positive selection at HA1 190
within subgroup I-v is quite unexpected.
Positive Selection of Egg-Adapted Human A(H1N1) HAs
during 1933,1979
To compensate for the lack of non-egg-adapted human
A(H1N1) HAs for the period of 1933,1978, we separately
collected a total of 32 different egg-adapted A(H1N1) HA
sequences between 1933,1979 that were free of sequence
ambiguity (Fig. S2). These sequences as a group were analyzed
by PAML 4.0, as well as two subgroups that covered the periods of
1947,1957 (12 sequences) and 1948,1979 (17 sequences)
(Table 4, 5), keeping in mind of the egg-adapted mutations at
HA1 138, 144, 163, 189, 190, 225, and 226 [62,63,64]. The two
subgroups 1947,1957 and 1948,1979 represented A(H1N1)
viruses circulating in the 1950s and in the 1970s upon its
reemergence in 1977, respectively. Given the close genetic and
antigenic similarity of the reappeared A(H1N1) influenza virus in
1977 with the A(H1N1) viruses isolated in 1950 [22,23,24], it was
of particular interest to investigate whether different evolutionary
trends were adopted by the 1947,1957 and 1948,1979
subgroups.
For both the entire group 1933,1979 and the subgroup
1947,1957, comparisons of M2a-M1a, M8-M7, or M8-M8a
yielded large LRT values and very small p-values, suggesting the
presence of positive selection at about 5% and 3% codons,
respectively (Table 4, 5). However, it is noteworthy that the
subgroup 1948,1979 had much smaller LRT values, suggesting
that the positive pressure of the entire group 1933,1979 be mostly
from the contribution of the subgroup 1947,1957.
We further employed the CODEML in PAML 4.0 to analyze
the positively selected codons in each group. The results were
shown in Table 5 where highlighted in bold were the codons not
known to be possible egg-adapted mutations (HA1 138, 144, 163,
189, 190, 225, and 226) [62,63,64]. For the entire group
1933,1979, HA1 77, 225 and 227 were found to be under
positive selection with greater than 95% posterior probability in
model M8 (Fig. 1b). They were located in the antigenic sites Cb
(HA1 77) and Ca2 (HA1 225 and 227), respectively (Fig. 1b). In
addition, for the subgroup 1948,1979, HA1 225 was found to be
under positive selection with greater than 99% posterior
probability in both models M2a and M8. However, given the
fact that these HAs were from egg-adapted A(H1N1) viruses in
which HA1 225 was one of the most frequently changed site
[62,63,64], and the predominant residue at this site (Table 6),
G225, was commonly found in swine and avian A(H1N1) HAs, it
was possible that the changes at HA1 225 was due to positive
selection imposed by adaptation in eggs. At posterior probability of
90%, HA1 138 and 189 were positively selected as well, however,
both sites were involved in egg-adapted substitutions [62,63,64]. In
sharp contrast, however, HA1 143, 166 and 264 in the subgroup
Table 2. LRT tests for HA1 sequences of human A(H1N1) influenza viruses.
LRT (M2a 2 M1a) (2Dl) (p-values)
1 LRT (M8 2 M7) (2Dl) (p-values)
1 LRT (M8 2 M8a) (2Dl) (p-values)
2
I-i 1918,1919 (5 strains) 3.44 (0.1791) 3.46 (0.1773) 3.44 (0.0318)
I-ii 1979,2000 (45 strains) 0 0 0
I-iii 2000,2001 (22 strains) 2.98 (0.2254) 2.84 (0.2417) 2.96 (0.0427)
I-iv 2001,2007 (89 strains) 1.86 (0.3946) 0.34 (0.8437) 1.16 (0.1407)
I-v 2006,2008 (100 strains) 62.42 (0.0000) 65.32 (0.0000) 61.70 (0.0000)
II 2007,2009 (74 strains) 0.78 (0.6771) 0.80 (0.6703) 2.44 (0.0591)
1We used the degree of freedom of 2 for these LRT tests that is expected to be too conservative.
2 The p-values were calculated from x
2 distribution using degree of
freedom of 1 that was then divided by a factor of 2 for the mixture distribution, as suggested by the author of PAML 4.0.
doi:10.1371/journal.pone.0007789.t002
Table 3. Codons under positive selection in HA1 of human
A(H1N1) influenza viruses.
Positively selected sites
1
I-v 2006,2008
(100 strains)
M2a 156 (97.5%), 190 (100%)
M8 156 (99.7%), 190 (100%)
1Positively selected sites from PAML 4.0 [45] using Bayes Empirical Bayes
analysis [72]. Only codons with greater than 95% posterior probabilities to be
under positive selection were listed with the corresponding posterior
probabilities shown in parentheses.
doi:10.1371/journal.pone.0007789.t003
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PLoS ONE | www.plosone.org 4 November 2009 | Volume 4 | Issue 11 | e7789Figure 1. Antigenic structure and positive selection of A(H1N1) HA. a) Antigenic structure of A/PR/8/34 (H1N1) HA (PDB accession code
1RU7 [78]). Five antigenic sites were identified by using a large number of monoclonal antibodies [73,74]: Sa (cyan), Sb (red), Ca1 (yellow), Ca2 (green),
Cb (blue), using H3 HA numbering. The receptor-binding site (RBS) was labeled for reference. b) Codons on A(H1N1) HA that were identified to be
under various selection in PAML and HyPhy analysis.
doi:10.1371/journal.pone.0007789.g001
Table 4. The values of log-likelihood (l), dN/dS, and parameter estimates in CODEML analysis of egg-adapted human A(H1N1) HAs
between 1933-1979.
Model l dN/dS Parameters estimates
1933,1979 (32 strains)
1
M0 (one-ratio) 23336.01 0.411 v=0.411
M1a (nearly neutral) 23283.75 0.336 p0=0.705 (p1=0.295), v0=0.057 (v1=1)
M2a (positive selection) 23275.24 0.454 p0=0.721, p1=0.234 (p2=0.046), v0=0.079 (v1=1), v2=3.571
M7 (beta) 23285.56 0.345 p=0.068, q=0.129
M8a (beta&v=1) 23283.78 0.336 p0=0.705 (p1=0.295), p=6.100, q=99,vs=1
M8 (beta&v.1) 23275.41 0.452 p0=0.942 (p1=0.058), p=0.206, q=0.534, vs=3.283
1947,1957 (12 strains)
1
M0 (one-ratio) 22068.01 0.435 v=0.435
M1a (nearly neutral) 22056.27 0.337 p0=0.689 (p1=0.311), v0=0.038 (v1=1)
M2a (positive selection) 22046.27 0.501 p0=0.967, p1=0(p2=0.033), v0=0.256 (v1=1),v2=7.651
M7 (beta) 22056.44 0.324 p=0.012, q=0.023
M8a (beta&v=1) 22056.28 0.337 p0=0.688 (p1=0.312), p=3.886, q=99,vs=1
M8 (beta&v.1) 22046.29 0.501 p0=0.967 (p1=0.033), p=34.141, q=99,vs=7.667
1948,1979 (17 strains)
1
M0 (one-ratio) 21759.58 0.385 v=0.385
M1a (nearly neutral) 21751.46 0.260 p0=0.740 (p1=0.260), v0=0(v1=1)
M2a (positive selection) 21747.17 0.408 p0=0.794, p1=0.168 (p2=0.039), v0=0(v1=1),v2=6.226
M7 (beta) 21751.61 0.300 p=0.005, q=0.012
M8a (beta&v=1) 21751.46 0.260 p0=0.740 (p1=0.260), p=0.005, q=2.350, vs=1
M8 (beta&v.1) 21747.19 0.411 p0=0.969 (p1=0.031), p=0.006, q=0.025, vs=6.964
1The analysis was performed on the first 337 residues of HA1 including the signal peptide.
doi:10.1371/journal.pone.0007789.t004
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none of which was among the previously identified egg-adapted
mutations. Antigenically, these codons were located in the
antigenic sites Ca2, Sa and Cb, respectively (Fig. 1b). For their
relatively distant location from the receptor-binding site, HA1 143,
166 and 264 are probably mutations driven by existing human
immunity for antibody escape.
Thus, there appeared to have different evolutionary patterns for
the subgroup 1947,1957 circulating in the 1950s and the
subgroup 1948,1979 circulating mostly in the 1970s. The former
subgroup was subjected to positive selection pressure at HA1 143,
166 and 264 (Table 5), and had a much larger variability at HA1
190, with 25% being non-D190 (Table 6). In marked contrast, the
latter subgroup was probably not under host-driven positive
selection in humans and had highly conserved HA1 190 (94.1%
being D190).
Evolution of Swine A(H1N1) HAs during 1990,2009
Given the swine origin of the 2009 pandemic A(H1N1) HA, we
also analyzed 42 non-redundant, non-ambiguous swine A(H1N1)
HA sequences during 1990,2009 available from GISAID/
Epifludb (Table 7, Fig. S3). The reason that we focused on this
period was mainly for the antigenic stasis of swine A(H1N1) until
1998 [8] since the introduction of the 1918 ‘‘Spanish’’ A(H1N1)
virus into swine [1,2,3,4,5,6,7,8]. Overall, the alternative models
M2a and M8 fitted the data only marginally better than the null
models M1a, M7 and M8a, respectively (Table 7). Thus, it seemed
that swine A(H1N1) HAs during 1990,2009 were not subjected
to strong host-driven positive selection.
Directional Evolution of Human A(H1N1) HAs
In order to test whether directional evolution of protein
sequences existed in the evolution of human A(H1N1) HAs, we
employed a maximum likelihood method developed by Kosa-
kovsky Pond and colleagues [49]. In each subgroup, we used the
oldest HA sequence as the root. In agreement with CODEML
analysis reported in previous sections, among all non-egg adapted
human A(H1N1) HAs, directional evolution was only identified in
the subgroup I-v, at sites HA1 143, 156, 158, 190, 193 and 197
(Table 8, 9). HA1 143 belonged to the antigenic site Ca2 of
A(H1N1) HA, whilst all other sites were located in the antigenic
site Sb (Fig. 1b). Among these sites, HA1 156, 190 and 193 were
identified by CODEML in PAML 4.0 to be under positive
selection with 99.7%, 100%, and 80.9% posterior probability in
model M8, respectively (Table 3). In previous structural studies,
residue HA1 190 in 1934 human A(H1N1) HA and HA1 190 and
193 in 1930 swine A(H1N1) HA were found to directly interact
with bound human-like a(2,6)-receptors [78]. Thus, it remains to
be investigated the impacts of directional evolution at HA1 190
and 193 on receptor binding and antigenic drift.
Table 5. LRT tests and codons under positive selection for HA1 sequences of egg-adapted human A(H1N1) influenza viruses
between 1933-1979.
LRT (2Dl) (p-values) Positively selected sites
1
1933,1979
(32 strains)
M2a M2a-M1a 17.02 (0.0002) 77 (95.8%), 225 (98.8%)
M8 M8-M7 20.30 (0.0000) 77 (98.7%), 225 (99.6%), 227 (97.7%)
M8-M8a 16.74 (0.0000)
1947,1957
(12 strains)
M2a M2a-M1a 20.0 (0.0000) 143 (99.3%), 264 (99.6%)
M8 M8-M7 20.30 (0.0000) 143 (99.6%), 166 (95.1%), 264 (99.7%)
M8-M8a 19.98 (0.0000)
1948,1979
(17 strains)
M2a M2a-M1a 8.58 (0.0137) 225 (99.1%)
M8 M8-M7 8.84 (0.0120) 225 (99.8%)
M8-M8a 8.54 (0.0017)
1Positively selected sites from PAML 4.0 [45] using Bayes Empirical Bayes analysis [72]. Only codons with greater than 95% posterior probabilities to be under positive
selection were listed with the corresponding posterior probabilities shown in parentheses. Highlighted in bold were codons that were not associated with egg-
adapted substitutions [62,63,64].
doi:10.1371/journal.pone.0007789.t005
Table 6. Codons at HA1 190 and 225 in human and swine A(H1N1) influenza viruses.
D190 Non-D190 D225 G225 Non-D225/G225
Human 1979,2008 Epidemic (575 sequences) 477 (83.0%)
* 98 (17.0%) 565 (98.2%) 2 (0.4%) 8 (1.4%)
Human 1918 Pandemic (5 sequences) 5 (100%) 0 3 (60%) 2 (40%) 0
Human 2009 Pandemic (73 sequences) 73 (100%) 0 69 (94.5%) 1 (1.4%) 3 (4.1%)
Human 1947,1957 (12 strains) (egg-adapted) 9 (75%) 3 (25%) 2 (16.7%) 10 (83.3%) 0
Human 1948,1979 (17 strains) (egg-adapted) 16 (94.1%) 1 (5.9%) 4 (23.5%) 13 (76.5%) 0
Swine 1990,2009 (42 sequences) 41 (97.6%) 1 (2.4%) 28 (66.6%) 12 (28.6%) 2 (4.8%)
*The number of cases that a particular type of residues occurs at each site. Shown in parenthesis was the occurrence in percentage.
doi:10.1371/journal.pone.0007789.t006
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human A(H1N1) HA sequences, and found that in both the entire
group 1933,1979 and the subgroup 1948,1979, multiple
favored mutations of D225RG and G225RD were detected
(Table 8, 9). Given its involvement in egg-adaptation, the
directional evolution at HA1 225 may be the consequence of
egg-adaptation. In contrast, no residues in the subgroup
1947,1957 were identified to be under directional selection.
Evolution of Human and Swine A(H1N1) HAs at HA1 190
and 225
For their predominant roles in determining receptor-binding
specificity of A(H1N1)HA,and the positive selection on HA1 190 in
the subgroup I-v, we further investigated the evolution of HA1 190
and 225 in A(H1N1) strains during 1918,1009. These included
653 non-egg-adapted HAs (five pandemic HAs from 1918,1919,
575 epidemic HAs from 1979,2008, and 73 pandemic HAs from
2009),and 42 swine HAs(Table 6).Forthe 575 epidemic HAs, HA1
190washighlyvariable(17.0%sequencesdidnot have D190),while
HA1 225 was more conserved (only 1.8% sequences did not have
D225) (Table 6). Among all the deviations (a total of 107 cases) from
the ideal D190/D225 combination for human A(H1N1) viruses,
two predominant ones were N190/D225 (69.2%) and V190/D225
(19.6%). At present, we don’t know the exact effects of these
mutations, or in combination with other concurring mutations at or
around the receptor-binding site, on binding to human receptors.
Further experiments are needed to clarify these issues. However, in
previous studies, a single mutation D190N of A(H1N1) HA was
shown to result in a lower binding affinity for human-like a(2,6)
receptors, and a higher binding affinity for avian-like a(2,3)
receptors [64].
The five HA sequences retrieved from victims of 1918
‘‘Spanish’’ A(H1N1) influenza virus shared 98.9% to 99.8%
sequence identity [11]. Among them, there were two non-
synonymous substitutions of D225G, one in A/New York/1/
1918 and the other one in A/London/1/1919 (Table 6). The HAs
harboring the mutation D225G had reduced binding affinity for
human receptors [11,40,41].
In the 73 HA sequences from the 2009 pandemic A(H1N1),
D190 was strictly conserved, while D225 was 94.5% conserved
(Table 6). At HA1 225, the deviations were 1.1% for G225 and
3.3% for E225. Thus, the complete conservation at HA1 190 and
the nearly complete conservation at HA1 225 were consistent to
the importance of these residues in allowing for binding to human-
like a(2,6) receptors [40,41], supporting the substantially higher
human-to-human transmissibility of the 2009 A(H1N1) virus than
seasonal A(H1N1) viruses [5,8].
Therefore, there were two distinct evolutionary trends in host-
driven antigenic drift of human A(H1N1) HAs at residues in the
receptor-binding site: the 1918 pandemic HAs underwent
antigenic drift at HA1 225, while the epidemic HAs undertook
antigenic drift at HA1 190. In the absence of selection, the 2009
A(H1N1) viruses were highly conserved at both HA1 190 and 225,
which was distinct from those two host-selected evolutionary
trends (Table 6). With gradually established immunity among
human population, we wondered how the 2009 A(H1N1) virus
would undergo antigenic drift in the months to come. Thus, we
also looked at the conservation at HA1 190 and 225 in 42 swine
A(H1N1) HA sequences (Table 6). Surprisingly, among these
sequences, D190 was conserved at 97.6%, while D225 and G225
were observed at 66.6% and 28.6%, respectively. The similarly
high variability of HA1 225 in swine A(H1N1) HAs with that of
1918 pandemic HAs was consistent with the relative antigenic
Table 7. The values of log-likelihood (l), dN/dS, and parameter estimates in CODEML analysis of swine A(H1N1) HAs between 1990–
2009.
Model l dN/dS Parameters estimates LRT (2Dl) (p-values)
M0 (one-ratio) 26021.08 0.158 v=0.158
M1a (nearly neutral) 25949.30 0.217 p0=0.864 (p1=0.136), v0=0.094 (v1=1) LRT (M2a-M1a) =1.24 (0.5379)
M2a (positive selection) 25948.68 0.224 p0=0.864, p1=0.134 (p2=0.002), v0=0.095
(v1=1),v2=3.682
M7 (beta) 25925.79 0.174 P=0.381, q=1.768 LRT (M8-M7) =6.78 (0.0337) LRT (M8-M8a) =3.40
(0.0326)
M8a (beta&v=1) 25924.10 0.171 p0=0.970 (p1=0.030), p=0.460, q=2.617, vs=1
M8 (beta&v) 25922.40 0.177 p0=0.995 (p1=0.005), p=0.413, q=2.052, vs=2.546
The analysis was performed on the first 338 residues of HA1 including the signal peptide.
doi:10.1371/journal.pone.0007789.t007
Table 8. Directional selection analysis on human A(H1N1) Has.
Tree L Residue P-Value Bias Proportion (%) No. of Sites
Human I-v (100 sequences) 0.474 T 0.0002 32.995 5.4 2
R 0.0002 12.583 11.8 1
V 0.0004 34.478 4.0 2
K 0.0023 29.301 7.2 1
Human 1933,1979 (32 strains) (egg-adapted) 0.613 D 0.0000 78.148 3.4 1
Human 1948,1979 (17 strains) (egg-adapted) 0.091 D 0.0007 133.611 5.1 1
doi:10.1371/journal.pone.0007789.t008
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suggestion that the introduction of the 2009 pandemic A(H1N1)
virus into humans be a single event or multiple events of similar
viruses [1,2,3,4,5,6,7,8].
The deviations from the ideal D190/D225 combination in
A(H1N1) HAs might result in reduced binding to human receptors
[11,41,42,64,79]. However, two possibilities, which are not
mutually exclusive, may explain the fact that mutations are
frequently observed at these two sites: one is that other concurring
mutations at or around the receptor-binding site may sufficiently
maintain the receptor binding affinity so that the overall binding
affinity is largely unaffected; the second is that the gain in evading
antibody neutralization far overweighs the reduction in receptor
binding. Due to the overlapping locations of the ever-changing
antigenic sites and the more-conserved receptor-binding site of
HA, there is a constant dilemma of whether or not a residue at the
receptor-binding site should change. Although the involvement of
residues in antigenic drift that are critical for receptor binding was
also observed in HAs of other types and subtypes including
influenza B virus HA [80], H3 [43,44]and H5 HA [44,81], the
interplay between these two opposing forces in HA evolution is still
very poorly understood. Although previous studies on A(H3N2)
HAs suggested covariation of antigenicity and receptor-binding
specificity as a possible mechanism for the antigenic differences
observed in viruses propagated in different cells [82], questions
such as how residues involved in receptor binding are actively
utilized for antigenic drift in influenza evolution in the same hosts
need to be urgently addressed in order for us to comprehend the
powerful strategies that the virus employs for recurring influenza
infections.
Implications for the 2009 Pandemic
By analyzing hundreds of A(H1N1) HA sequences between
1918,2009, our study revealed positive selection in the subgroup
I-v of A(H1N1) HAs. The positively selected codons were located
at HA1 156 and 190 in the Sb antigenic site [83]. It was surprising
that HA1 190, which is critical for receptor-binding specificity of
A(H1N1) HAs, was also under positive selection. Through further
analysis of HA1 190, together with HA1 225, the other critical
determinant for receptor-binding specificity of A(H1N1), we found
that the epidemic HAs and the 1918 pandemic and swine HAs
favored one of these two sites for antigenic drift. Whether the 2009
pandemic A(H1N1) HA will adopt any of these two trends, or use
a novel mechanism that does not involve HA1 190 and 225, will
unfold in the coming months. If the latter is to be used, the 2009
A(H1N1) viruses may maintain their intrinsic high transmissibility,
which, together with mutations in other genes such as NS1 and
PB1-F2 with signatures of elevated pathogenicity [1,2], may suffice
a new disastrous pandemic in the near future.
Materials and Methods
Phylogenetic Analysis of A(H1N1) HAs
We obtained all available HA sequences (over 1,000) of non-
egg-adapted A(H1N1) viruses for the period of 1918,2009 (as of
July 10, 2009) from GISAID/Epifludb. We then removed the
sequences with one or more ambiguous nucleotide sequences
within the HA1 region and deleted identical sequences. This gave
us a dataset of 652 HA sequences that included three 1918
pandemic HAs, 575 epidemic HAs from 1979,2008 that
collectively formed group I, and 73 pandemic HAs from 2009
and one HA from 2007 that belonged to group II. To facilitate the
speed of computing, we further removed closely related sequences
and obtained a dataset of 333 HA sequences. The program RDP3
(http://darwin.uvigo.es/rdp/rdp.html) [66] was used to make sure
that no recombination was present in any of these HA sequences.
The ClustalW method [68] with the MEGALIGN program of
DNASTAR package (www.dnastar.com) was used for phyloge-
netic analysis of H1 HA sequences in the region of HA1 (Fig. S1).
Due to the historic use of eggs for amplification of influenza
viruses before sequencing, there presented a vacuum in sequence
for non-egg-adapted A(H1N1) viruses between 1919 and 1979. In
order to gain insights into the evolution of A(H1N1) viruses for this
period, we separately collected a total of 32 different egg-adapted
A(H1N1) HA sequences between 1933,1979 that were free of
sequence ambiguity (Fig. S2). These sequences were similarly
analyzed while keeping in mind of the possible egg-adapted
mutations at HA1 138, 144, 163, 189, 190, 225, and 226
[62,63,64].
In order to compare the evolution of swine A(H1N1) HA
sequences, we also retrieved 42 unique swine H1 HA sequences
for the period of 1990,2009 that were free of ambiguous
nucleotide sequences (Fig. S3). The reason that we focused on
1990,2009 was that previous studies suggested that swine
A(H1N1) viruses be antigenically stable for the period of 1930 to
1990s [84].
Analysis of Positive Selection by PAML 4.0
The site-specific models implemented in the CODEML
program in PAML 4.0 [45] was used to calculate heterogeneous
selection pressure at amino-acid positions [45,54,72,85]. The
models used in this study were M0, M1a, M2a, M7 and M8. M1a
(nearly neutral), M7 (beta) and M8a (beta and v=1) were null
models that did not support v.1. In contrast, the alternative
Table 9. Sites found to be under directional selection in human A(H1N1) Has.
Sites Composition Root Preferred Inferred Substitutions
Human I-v (100 sequences) 143 V99T1 VV T R1V
156 G90R9E1 RR G R1E, GR7R
158 N96K4 NK N R4K
190 D67N25V8 DV D R16N, DR4V
193 A52T48 AT A R6T
197 T82K18 TT K R2T
Human 1933,1979 (32 strains) (egg-adapted) 225 G23D9 DD D R1G, GR6D
Human 1948,1979 (17 strains) (egg-adapted) 225 G13D4 GD G R4D
doi:10.1371/journal.pone.0007789.t009
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M1a and M7 respectively, each had an additional class that
allowed v.1. Likelihood ratio tests (LRT) comparing M2a versus
M1a, M8 versus M7, and M8 versus M8a provided test for the
existence of positive selection. In the test, twice the log likelihood
difference, 2Dl=2(l12l0), was calculated where l1and l0were the
log likelihoods for the alternative model and null model,
respectively. A larger value of LRT over those of x
2 distribution
led to rejection of the null models [72]. In order to calculate the
codon-substitution models for heterogeneous selection pressure at
each codon, the Bayes Empirical Bayes (BEB) analysis imple-
mented in CODEML [72] was used, which has been shown to
yield robust results even for small datasets. For all calculations,
multiple runs, each with different initial parameter values, were
performed to ensure optimization and convergence.
Directional Evolution of Protein Sequences Using HyPhy
Each group of A(H1N1) HA sequences aligned by the ClustalW
method (Fig. S1, S2, S3) was input to the PhyML program [86] to
generate an unrooted phylogenetic tree, which was then rooted
using the Treeview software [87] by selecting the oldest sequence
in each group as the root/ancestor. This rooted phylogenetic tree
was used for directional evolution of protein sequences [49]
implemented in the HyPhy [55] software package.
Supporting Information
Figure S1 Phylogenetic tree of 333 HA sequences of A
(H1N1) influenza viruses isolated between 1918,2009 without
egg-adaptation.
Found at: doi:10.1371/journal.pone.0007789.s001 (41.64 MB
TIF)
Figure S2 Phylogenetic tree of 32 HA sequences of egg-adapted
human A(H1N1) influenza viruses isolated between 1933,1979.
Found at: doi:10.1371/journal.pone.0007789.s002 (1.02 MB TIF)
Figure S3 Phylogenetic tree of 42 HA sequences of swine
A(H1N1) influenza viruses isolated between 1990,2009.
Found at: doi:10.1371/journal.pone.0007789.s003 (1.39 MB TIF)
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